ClinicalTrials.govpublic full text
Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease
parkinson disease, parkinson disease dementia, cognitive impairment, wearable sensor, gait analysis, rivastigmine, cholinesterase inhibitor, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 812503
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.